亚虹医药跌7.91% 2022上市即巅峰募25亿中信证券保荐

Core Viewpoint - Yahui Pharmaceutical (688176.SH) is currently trading at 13.15 yuan, reflecting a decline of 7.91%, and is in a state of share price decline since its IPO [1] Group 1: IPO Details - Yahui Pharmaceutical was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 7, 2022, with an issuance of 110 million shares at a price of 22.98 yuan per share [1] - The stock price fell below the IPO price on the first trading day, reaching a maximum of 20.00 yuan, which was the highest price since its listing [1] - The total funds raised from the IPO amounted to 2.528 billion yuan, with a net amount of 2.381 billion yuan after deducting issuance costs, exceeding the original plan by 311 million yuan [1] Group 2: Fund Utilization - The funds raised are intended for projects including drug and medical device production, new drug research and development, marketing network construction, and working capital supplementation [1] Group 3: Underwriting and Fees - The total cost of the IPO was 147 million yuan, with CITIC Securities receiving 130 million yuan as underwriting and sponsorship fees [1]